Holen Sie sich die Stockscreener-App
4.42
2.08%
0.09
Vorhandelsmarkt:
4.37
-0.05
-1.13%
Schlusskurs vom Vortag:
$4.33
Offen:
$4.36
24-Stunden-Volumen:
38,102
Relative Volume:
0.28
Marktkapitalisierung:
$17.67M
Einnahmen:
$1.23M
Nettoeinkommen (Verlust:
$-12.15M
KGV:
-1.0227
EPS:
-4.3221
Netto-Cashflow:
$-13.60M
1W Leistung:
+12.76%
1M Leistung:
+2.55%
6M Leistung:
-12.68%
1J Leistung:
-65.47%
1-Tages-Spanne:
$4.315
$4.48
1-Wochen-Bereich:
$3.7206
$4.58
52-Wochen-Spanne:
$2.07
$13.40
Seastar Medical Holding Corp Stock (ICU) Company Profile
Firmenname
Seastar Medical Holding Corp
Sektor
Branche
Telefon
844-427-8100
Adresse
3513 BRIGHTON BLVD, DENVER
Compare ICU vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICU
Seastar Medical Holding Corp
|
4.42 | 17.67M | 1.23M | -12.15M | -13.60M | -4.3221 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Seastar Medical Holding Corp Aktie (ICU) Neueste Nachrichten
SeaStar Medical (NASDAQ: ICU) seeks approval to expand 2022 equity incentive plan - Stock Titan
SeaStar Medical (NASDAQ: ICU) registers 65,068 resale shares; warrants could bring $74M - Stock Titan
SeaStar Medical (NASDAQ: ICU) updates S-1; registers 493,542 shares and related warrants - Stock Titan
SeaStar Medical (NASDAQ: ICU) files S-1 for Lincoln Park resale facility - Stock Titan
Securities class action against SeaStar Medical (NASDAQ: ICU) dismissed with prejudice - Stock Titan
ICU DEADLINE TOMORROW: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages SeaStar Medical Holding Corporation Investors to Secure Counsel Before Important September 6 Deadline in Securities Class ActionICU - TMX Newsfile
ICUCW (SeaStar) quarterly earnings results have not been disclosed, with no performance or stock reaction data available.Verified Analyst Reports - Newser
SeaStar (ICU) Stock: Why Network Effect (Dips) 2026-04-20Trending Social Stocks - Newser
SeaStar (ICU) Stock Discretionary Trade (+2.93%) 2026-04-15Crowd Entry Points - Newser
Is SeaStar (ICU) Stock at a Peak | Price at $4.10, Up 10.51%Quote Data - Newser
RSI Check: Can SeaStar Medical Holding Corporation Equity Warrant reach all time highs this year - baoquankhu1.vn
Trade Report: What are the future prospects of SeaStar Medical Holding CorporationInsider Selling & Real-Time Volume Spike Alerts - baoquankhu1.vn
US Market Recap: Is SeaStar Medical Holding Corporation Equity Warrant still a buy after recent gains2026 Top Gainers & Precise Entry and Exit Recommendations - baoquankhu1.vn
SeaStar Medical (NASDAQ:ICU) & Selectis Health (OTCMKTS:GBCS) Critical Comparison - Defense World
Market Catalysts: Whats the MACD signal for SeaStar Medical Holding Corporation2026 Price Targets & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Pullback Watch: Can SeaStar Medical Holding Corporation continue delivering strong returns2026 Setups & Safe Entry Trade Signal Reports - baoquankhu1.vn
ICU PE Ratio & Valuation, Is ICU Overvalued - Intellectia AI
SeaStar Medical presents pediatric AKI data at conference - Investing.com
Risks Report: Can SeaStar Medical Holding Corporation Equity Warrant continue delivering strong returnsPortfolio Update Summary & Fast Gaining Stock Reports - baoquankhu1.vn
Trend Recap: Can SeaStar Medical Holding Corporation Equity Warrant reach all time highs this year2026 Top Gainers & Precise Entry and Exit Recommendations - baoquankhu1.vn
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
SeaStar Medical presents pediatric AKI data at conference By Investing.com - ca.investing.com
SeaStar Medical Reports Positive SAVE Registry Data on Pediatric AKI Treatment and Hosts Expert Symposium - Quiver Quantitative
New pediatric AKI data show 69% survival with no device issues - Stock Titan
SeaStar Medical Showcases New Positive Data from the QUELIMMUNE SAVE Registry and an Analysis of the Unique Immunomodulatory Mechanism of the SCD Therapy at AKI & CRRT 2026 - Yahoo Finance
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
SeaStar Medical Holding Corp (ICU) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Gains Report: Can SeaStar Medical Holding Corporation Equity Warrant reach all time highs this year2026 Trade Ideas & AI Based Buy and Sell Signals - baoquankhu1.vn
SeaStar Medical Holding Corp reports results for the quarter ended September 30Earnings Summary - TradingView
Earnings call transcript: SeaStar Medical’s Q4 2025 revenue soars, stock edges up - Investing.com Australia
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
SeaStar Medical Holding 2025 10-K: Revenue $1.234M, EPS $(5.86) - TradingView
SeaStar Medical (NASDAQ: ICU) details QUELIMMUNE launch and pivotal AKI trial - Stock Titan
SEASTAR MEDICAL HOLDING ($ICU) Releases Q4 2025 Earnings - Quiver Quantitative
SeaStar Medical reports $1.2M revenue for 2025, narrows annual loss to $12.2M - TradingView
[8-K] SeaStar Medical Holding Corp Reports Material Event - Stock Titan
SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates - ChartMill
SeaStar Medical Holding Corp expected to post a loss of $1.06 a shareEarnings Preview - TradingView
If You Invested $1,000 in SeaStar Medical Holding Corp (ICU) - Stock Titan
ICU Technical Analysis & Stock Price Forecast - Intellectia AI
Aug Catalysts: Can SeaStar Medical Holding Corporation continue delivering strong returnsSell Signal & Reliable Intraday Trade Alerts - baoquankhu1.vn
EV Market: Can SeaStar Medical Holding Corporation be the next market leaderQuarterly Growth Report & Fast Moving Trade Plans - baoquankhu1.vn
SeaStar Medical Highlights SCD Platform, QUELIMMUNE Growth and NEUTRALIZE-AKI Timeline at Forum - Defense World
Insider Buy: Will SeaStar Medical Holding Corporation stock recover after earnings2026 Top Decliners & Accurate Technical Buy Alerts - baoquankhu1.vn
SeaStar Medical (ICU) Expected to Announce Earnings on Thursday - Defense World
SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026 - ChartMill
OTC Markets Hosts Virtual Investor Presentation with Eric Schlorff, CEO of SeaStar Medical, and David Bautz, PhD, Senior Analyst at Zacks SCR - Yahoo Finance
Trend Report: How does SeaStar Medical Holding Corporation compare to its peers2026 Buyback Activity & AI Forecast Swing Trade Picks - baoquankhu1.vn
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing - GlobeNewswire
Signal Recap: Does SeaStar Medical Holding Corporation offer margin of safetyTrend Reversal & Safe Entry Zone Tips - baoquankhu1.vn
B2i Digital Highlights Life Sciences Virtual Investor Forum as a Featured Conference - TradingView
Finanzdaten der Seastar Medical Holding Corp-Aktie (ICU)
Umsatz
Nettogewinn
Free Cashflow
ENV
Seastar Medical Holding Corp-Aktie (ICU) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Messinger Michael | Chief Financial Officer |
Dec 09 '25 |
Buy |
0.35 |
14,500 |
5,098 |
17,500 |
| Van Heel Kenneth | Director |
Aug 26 '25 |
Buy |
0.89 |
25,000 |
22,248 |
39,400 |
| Van Heel Kenneth | Director |
Aug 27 '25 |
Buy |
0.86 |
10,000 |
8,565 |
49,400 |
| Chung Kevin | Chief Medical Officer |
Aug 22 '25 |
Buy |
0.80 |
10,000 |
8,000 |
58,184 |
| Neuman John | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
2,667 |
0 |
88,000 |
| Vincent Bernadette N | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
2,667 |
0 |
8,000 |
| Van Heel Kenneth | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
4,000 |
0 |
10,400 |
| Chung Kevin | Chief Medical Officer |
Jul 01 '25 |
Option Exercise |
0.00 |
5,000 |
0 |
48,184 |
| Schlorff Eric | Chief Executive Officer |
Jul 01 '25 |
Option Exercise |
0.00 |
21,667 |
0 |
98,517 |
| Baird Jennifer A | Director |
Jun 04 '25 |
Option Exercise |
0.00 |
2,667 |
0 |
18,000 |
0.14%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):